INCREASED RISK OF ANTI-DRUG ANTIBODIES TO A SECOND ANTI-TNF IN PATIENTS WHO DEVELOPED ANTIBODIES TO THE FIRST ANTI-TNF

被引：0
|
作者：
Yanai, Henit A.
Amir, Shira
Avni-Biron, Irit
Perets, Tsachi Tsadok
Shamir, Raanan
Dotan, Iris
Assa, Amit
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1841
引用
收藏
页码：S671 / S671
页数：1
相关论文
共 50 条
  • [1] Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF
    Yanai, H.
    Amir, S.
    Biron, I. Avni
    Perets, T. Tsadok
    Shamir, R.
    Dotan, I.
    Assa, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S439 - S439
  • [2] ANTI-DRUG ANTIBODIES AS A PREDICTOR FOR THE DISCONTINUATION OF ANTI-TNF AGENTS IN PATIENTS WITH SPONDYLOARTHRTIS
    Kim, H. J.
    Hwang, J.
    Kim, I.
    Jeong, H.
    Lee, J.
    Jeon, C. H.
    Koh, E. -M.
    Cha, H. -S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 717 - 718
  • [3] ANTI-DRUG ANTIBODIES: ASSAY PERFORMANCE IN PATIENTS TREATED WITH ANTI-TNF BIODRUGS
    Hock, B.
    O'donnell, J. L.
    Liu, J.
    Keating, P.
    Spellerberg, M.
    Stamp, L.
    Barclay, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1415 - 1415
  • [4] LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF
    Cheifetz, Adam S.
    Abreu, Maria T.
    Flier, Sarah N.
    Papamichail, Konstantinos
    Rieder, Florian
    Silverberg, Mark S.
    Khanna, Reena
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Vande Casteele, Niels
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S457 - S457
  • [5] Anti-Drug Antibodies As a Predictor for the Discontinuation of Anti-TNF Agents in Patients with Spondyloarthrtis.
    Hwang, Jiwon
    Kim, In Young
    Lee, Seulkee
    Jeong, Hyemin
    Kim, Hyungjin
    Lee, Jaejoon
    Koh, Eun-mi
    Cha, Hoon-Suk
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S263 - S263
  • [6] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Nicholas J. Costable
    Zachary A. Borman
    Jiayi Ji
    Marla C. Dubinsky
    Ryan C. Ungaro
    [J]. Digestive Diseases and Sciences, 2022, 67 : 2480 - 2484
  • [7] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Costable, Nicholas J.
    Borman, Zachary A.
    Ji, Jiayi
    Dubinsky, Marla C.
    Ungaro, Ryan C.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2480 - 2484
  • [8] PRIOR IMMUNOGENICITY TO ANTI-TNF BIOLOGICS IS NOT ASSOCIATED WITH INCREASED ANTI-DRUG ANTIBODIES TO VEDOLIZUMAB OR USTEKINUMAB
    Costable, Nicholas J.
    Borman, Zachary A.
    Phan, Becky L.
    Ji, Jiayi
    Dubinsky, Marla
    Ungaro, Ryan C.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S468 - S469
  • [9] INCREASED FREQUENCY OF ANTI-DRUG ANTIBODIES IN PATIENTS CARRYING COMPATIBLE IGG1 ALLOTYPES AND TREATED WITH ANTI-TNF ANTIBODIES
    Lopez-Rodriguez, R.
    Martinez, A.
    Plasencia, C.
    Jochems, A.
    Pascual-Salcedo, D.
    Balsa, A.
    Gonzalez, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 59 - 59
  • [10] Increased Frequency of Anti-Drug Antibodies in Patients Carrying Compatible IgG1 Allotypes and Treated with Anti-TNF Antibodies
    Gonzalez, Antonio
    Lopez-Rodriguez, Rosario
    Martinez, Ana
    Plasencia-Rodriguez, Chamaida
    Jochems, Andrea
    Pascual-Salcedo, Dora
    Balsa, Alejandro
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345